|Hu: Unmasking Conserved Epitopes
|Combo: Protein & vector vaccines
|Study Start Date:
|Study Made Public:
Cytoplasmic tail modifications in HIV-1/JRFL Env can improve the Env-specific antibody response
CAVD 483 (MU8) is a preclinical mouse study to demonstrate whether cytoplasmic tail mutations which increase cell surface expression of Env exhibit increased immunogenicity in a vaccinia prime/boost regimen.
Sign in to see full information about this study and to download study data.